In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Society for Reproductive Immunology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco LLC designates this LIVE activity for a maximum of 33.0 AMA PRA Category 1 Credits^TM. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

At the conclusion of the meeting, all participants should be able to:

1. Summarize recent advances in understanding of mechanism of action and potential interventions including vaccines to combat infections of the reproductive tract.
2. Explain new and novel technologies in the field of reproductive immunology that permit access to early in utero environment.
3. Evaluate the latest cutting edge research to understand developmental origins of adult health.
4. Value being an active participant in making the academic environment more equitable and inclusive.

Participants must attend sessions and complete an evaluation survey to receive a certificate of completion. Partial credit of individual sessions is not available. NOTE: It is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

A maximum of 33.0 credits may be earned during the 2024 meeting.  *1 CME credit = 1 hour of educational content.  

Credits are broken down as follows:

CME certificates will be available for attendees who participate in live sessions.  At the conclusion of the meeting, you will be able to claim your certificate for the sessions you attended.